Induction of hepatitis B core protein aggregation targeting an unconventional binding site
The hepatitis B virus (HBV) infection is a major global health problem, with chronic infection leading to liver complications and high death toll. Current treatments, such as nucleos(t)ide analogs and interferon-α, effectively suppress viral replication but rarely cure the infection. To address this...
Saved in:
| Main Authors: | Vladimir Khayenko, Cihan Makbul, Clemens Schulte, Naomi Hemmelmann, Sonja Kachler, Bettina Böttcher, Hans Michael Maric |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2025-03-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/98827 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence and Transfusion Risks of Occult Hepatitis B Infection Among HBcAb-Positive Blood Donors in a High-Endemic Region
by: Ahmed Subeh Alshrari, et al.
Published: (2025-02-01) -
Occult hepatitis B- viral infections among blood donors in Duhok-Iraq
by: Noor Rizqo Mikha, et al.
Published: (2025-03-01) -
Safety, pharmacokinetics, and antiviral efficacy of the novel capsid assembly modulator GST-HG141 in patients with chronic hepatitis B: a phase 1 trial with a randomized, placebo-controlled design
by: Min Wu, et al.
Published: (2024-12-01) -
Computational Approaches to Predict Hepatitis B Virus Capsid Protein Mutations That Confer Resistance to Capsid Assembly Modulators
by: Gideon Tolufashe, et al.
Published: (2025-02-01) -
Booster immunity – diagnosis of chronic hepatitis B viral infection
by: Radka T Komitova, et al.
Published: (2019-03-01)